Remove 2003 Remove FDA Remove Governance
article thumbnail

Building a Quality Education Program That’s Good Enough 

YouCompli

From there, look at the regulations that govern your organization and see what applies so you include it. If you are in clinical research, this means looking at the FDA requirements, ICH-GCP Guidelines, and other applicable regulations. John is the Director of Quality at Sunrise Vista in Canton, Ohio.

Nurses 52
article thumbnail

Healthcare Cybersecurity – 2024 Health IT Predictions

Healthcare IT Today

The HIPAA Security Rule was drafted in 2003 and has not been substantively updated since that time. While this issue has gained the attention of the government, leading them to release the National Cybersecurity Workforce and Education Plan, the reality is that it will take a significant amount of time to bridge this gap.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which Situations Allow a Medical Professional to Release Information?

HIPAA Journal

The page reveals that, since 2003, the agency has received more than 300,000 complaints alleging violations of HIPAA. To the Federal Drug Administration to report adverse events and track FDA-regulated products. To personal representatives of adult patients and unemancipated minor patients.

HIPAA 74
article thumbnail

Is Human Tissue A Product?

Drug & Device Law

Medical products based on human tissue have been around for a long time, and they are regulated by the FDA. 18, 2024), which applied the Illinois statute governing blood and organ transactions to dismiss strict liability and warranty claims. 2d 640, 653 (2003)). That is the holding of Zydek v. Aziyo Biologics, Inc. ,

FDA 52
article thumbnail

Reporter’s Privilege Protects JAMA Peer-Review Documents from Discovery

Drug & Device Law

GlaxoSmithKline , 2023 IL App (1st) 221666 (2003). Information disclosed in JAMA’s privilege log revealed that JAMA had communicated with an unidentified government official in connection with its decision to drop the original version of the article at issue. The court granted the motion and JAMA appealed.

FDA 64
article thumbnail

NPP, DCC, And FDA-Regulated Medical Products

Drug & Device Law

We are not looking do either of those, but we will weigh in on what NPP means for non-product liability cases involving FDA-regulated medical products. Both talk a fair amount about “commerce” and the respective roles of the states and federal government. 644 (2003), but not to Pike. Walsh , 538 U.S.

FDA 59
article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

But in prescription medical product liability litigation, products must receive FDA approval, clearance or other authorization (hereafter, collectively referred to as “approval” for short) before they can be marketed. Are manufacturers liable only for failing to employ an alternative design that the FDA has approved for distribution. . .

FDA 59